A citation-based method for searching scientific literature

Mitsutoshi Tominaga, Hideoki Ogawa, Kenji Takamori. J Invest Dermatol 2007
Times Cited: 98







List of co-cited articles
1313 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of pruritus with topically applied opiate receptor antagonist.
Paul L Bigliardi, Holger Stammer, Gerhard Jost, Theo Rufli, Stanislaw Büchner, Mei Bigliardi-Qi. J Am Acad Dermatol 2007
81
32

The neurobiology of itch.
Akihiko Ikoma, Martin Steinhoff, Sonja Ständer, Gil Yosipovitch, Martin Schmelz. Nat Rev Neurosci 2006
617
24

IL-31: a new link between T cells and pruritus in atopic skin inflammation.
Eniko Sonkoly, Anja Muller, Antti I Lauerma, Andor Pivarcsi, Hortensia Soto, Lajos Kemeny, Harri Alenius, Marie-Caroline Dieu-Nosjean, Stephan Meller, Juliane Rieker,[...]. J Allergy Clin Immunol 2006
613
19

Expression of mu-opiate receptor in human epidermis and keratinocytes.
P L Bigliardi, M Bigliardi-Qi, S Buechner, T Rufli. J Invest Dermatol 1998
92
20

Opioids and the skin--where do we stand?
Paul L Bigliardi, Desmond J Tobin, Claire Gaveriaux-Ruff, Mei Bigliardi-Qi. Exp Dermatol 2009
87
21


Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Thomas Ruzicka, Jon M Hanifin, Masutaka Furue, Grazyna Pulka, Izabela Mlynarczyk, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida,[...]. N Engl J Med 2017
322
18

A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.
Ferda Cevikbas, Xidao Wang, Tasuku Akiyama, Cordula Kempkes, Terhi Savinko, Attila Antal, Gabriela Kukova, Timo Buhl, Akihiko Ikoma, Joerg Buddenkotte,[...]. J Allergy Clin Immunol 2014
390
18

Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Björn Wikström, Ryszard Gellert, Søren D Ladefoged, Yasuaki Danda, Masahiko Akai, Kaoru Ide, Midori Ogasawara, Yoshiharu Kawashima, Koki Ueno, Akio Mori,[...]. J Am Soc Nephrol 2005
201
17

Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study.
Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Taro Muramatsu, Hidetomo Nakamoto, Hiromichi Suzuki. Nephrol Dial Transplant 2010
199
17

Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Ngoc Quan Phan, Tobias Lotts, Attila Antal, Jeffrey D Bernhard, Sonja Ständer. Acta Derm Venereol 2012
81
20

Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch.
Landon K Oetjen, Madison R Mack, Jing Feng, Timothy M Whelan, Haixia Niu, Changxiong J Guo, Sisi Chen, Anna M Trier, Amy Z Xu, Shivani V Tripathi,[...]. Cell 2017
461
17

Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch.
Kenichi Taneda, Mitsutoshi Tominaga, Osamu Negi, Suhandy Tengara, Atsuko Kamo, Hideoki Ogawa, Kenji Takamori. Br J Dermatol 2011
69
23

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Eric L Simpson, Thomas Bieber, Emma Guttman-Yassky, Lisa A Beck, Andrew Blauvelt, Michael J Cork, Jonathan I Silverberg, Mette Deleuran, Yoko Kataoka, Jean-Philippe Lacour,[...]. N Engl J Med 2016
973
16

Butorphanol for treatment of intractable pruritus.
Aerlyn G Dawn, Gil Yosipovitch. J Am Acad Dermatol 2006
121
14

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
Sonja Ständer, Dorothee Siepmann, Ilka Herrgott, Cord Sunderkötter, Thomas A Luger. PLoS One 2010
191
14

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.
Sarah R Wilson, Lydia Thé, Lyn M Batia, Katherine Beattie, George E Katibah, Shannan P McClain, Maurizio Pellegrino, Daniel M Estandian, Diana M Bautista. Cell 2013
569
14


Frontiers in pruritus research: scratching the brain for more effective itch therapy.
Ralf Paus, Martin Schmelz, Tamás Bíró, Martin Steinhoff. J Clin Invest 2006
264
13

Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
Yuko Togashi, Hideo Umeuchi, Kiyoshi Okano, Naoki Ando, Yoshitaka Yoshizawa, Toshiyuki Honda, Kuniaki Kawamura, Takashi Endoh, Jun Utsumi, Junzo Kamei,[...]. Eur J Pharmacol 2002
163
13

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.
Stacey R Dillon, Cindy Sprecher, Angela Hammond, Janine Bilsborough, Maryland Rosenfeld-Franklin, Scott R Presnell, Harald S Haugen, Mark Maurer, Brandon Harder, Janet Johnston,[...]. Nat Immunol 2004
648
13

Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin.
Sonja Ständer, Matthias Gunzer, Dieter Metze, Thomas Luger, Martin Steinhoff. Regul Pept 2002
73
16

Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis.
M Bigliardi-Qi, B Lipp, L T Sumanovski, S A Buechner, P L Bigliardi. Dermatology 2005
60
20


Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Ngoc Quan Phan, Jeffrey D Bernhard, Thomas A Luger, Sonja Ständer. J Am Acad Dermatol 2010
104
12

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
Lisa A Beck, Diamant Thaçi, Jennifer D Hamilton, Neil M Graham, Thomas Bieber, Ross Rocklin, Jeffrey E Ming, Haobo Ren, Richard Kao, Eric Simpson,[...]. N Engl J Med 2014
826
12

Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.
Mei Bigliardi-Qi, Claire Gaveriaux-Ruff, Katrin Pfaltz, Pierre Bady, Tommy Baumann, Theo Rufli, Brigitte L Kieffer, Paul L Bigliardi. J Invest Dermatol 2007
45
24



Clinical classification of itch: a position paper of the International Forum for the Study of Itch.
Sonja Ständer, Elke Weisshaar, Thomas Mettang, Jacek C Szepietowski, Earl Carstens, Akihiko Ikoma, Nora V Bergasa, Uwe Gieler, Laurent Misery, Joanna Wallengren,[...]. Acta Derm Venereol 2007
393
11

Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients.
Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Katsumasa Miyasato, Taro Muramatsu, Hidetomo Nakamoto, Masanao Kurihara, Tomoji Yanagita, Hiromichi Suzuki. Am J Nephrol 2012
95
11

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
Amy S Paller, Wynnis L Tom, Mark G Lebwohl, Robin L Blumenthal, Mark Boguniewicz, Robert S Call, Lawrence F Eichenfield, Douglass W Forsha, William C Rees, Eric L Simpson,[...]. J Am Acad Dermatol 2016
286
11

Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial.
Gil Yosipovitch, Sonja Ständer, Matthew B Kerby, James W Larrick, Andrew J Perlman, Edward F Schnipper, Xiaoming Zhang, Jean Y Tang, Thomas Luger, Martin Steinhoff. J Am Acad Dermatol 2018
73
15


Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus.
Qin Liu, Zongxiang Tang, Lenka Surdenikova, Seungil Kim, Kush N Patel, Andrew Kim, Fei Ru, Yun Guan, Hao-Jui Weng, Yixun Geng,[...]. Cell 2009
524
10

TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms.
Noritaka Imamachi, Goon Ho Park, Hyosang Lee, David J Anderson, Melvin I Simon, Allan I Basbaum, Sang-Kyou Han. Proc Natl Acad Sci U S A 2009
313
10

Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Nicholas K Mollanazar, Peter K Smith, Gil Yosipovitch. Clin Rev Allergy Immunol 2016
181
10

Topical nalfurafine exhibits anti-inflammatory and anti-pruritic effects in a murine model of AD.
Graham Elliott, Raymond Vanwersch, Michael Soeberdt, Dieter Metze, Tobias Lotts, Sonja Ständer, Christoph Abels. J Dermatol Sci 2016
19
52

Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin.
M Bigliardi-Qi, L T Sumanovski, S Büchner, T Rufli, P L Bigliardi. Dermatology 2004
85
10

Detection of kappa and delta opioid receptors in skin--outside the nervous system.
Souzan Salemi, André Aeschlimann, Natasa Reisch, Astrid Jüngel, Renate E Gay, Frank L Heppner, Beat A Michel, Steffen Gay, Haiko Sprott. Biochem Biophys Res Commun 2005
34
26

Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
Hideo Umeuchi, Yuko Togashi, Toshiyuki Honda, Kaoru Nakao, Kiyoshi Okano, Toshiaki Tanaka, Hiroshi Nagase. Eur J Pharmacol 2003
96
9

Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing.
Mei Bigliardi-Qi, Claire Gaveriaux-Ruff, Hayan Zhou, Clarisse Hell, Pierre Bady, Theo Rufli, Brigitte Kieffer, Paullorenz Bigliardi. Differentiation 2006
46
19

Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin.
Martin Steinhoff, Ulrich Neisius, Akihiko Ikoma, Manigé Fartasch, Gisela Heyer, Per S Skov, Thomas A Luger, Martin Schmelz. J Neurosci 2003
382
9

Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis.
M Toyoda, M Nakamura, T Makino, T Hino, M Kagoura, M Morohashi. Br J Dermatol 2002
225
9


Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.
David Roblin, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Valentina Mainero, Ro Wickramasinghe, Uma Anand, Praveen Anand. Acta Derm Venereol 2015
72
12

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
Eric L Simpson, Carsten Flohr, Lawrence F Eichenfield, Thomas Bieber, Howard Sofen, Alain Taïeb, Ryan Owen, Wendy Putnam, Marcela Castro, Kendra DeBusk,[...]. J Am Acad Dermatol 2018
179
9

Opioid Receptors in Psoriatic Skin: Relationship with Itch.
Piotr Kupczyk, Adam Reich, Marcin Hołysz, Mariusz Gajda, Edyta Wysokińska, Anna Kobuszewska, Dmitry Nevozhay, Beata Nowakowska, Leon Strzadała, Paweł Poitr Jagodziński,[...]. Acta Derm Venereol 2017
26
34

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
Mohab M Ibrahim, Frank Porreca, Josephine Lai, Phillip J Albrecht, Frank L Rice, Alla Khodorova, Gudarz Davar, Alexandros Makriyannis, Todd W Vanderah, Heriberto P Mata,[...]. Proc Natl Acad Sci U S A 2005
387
8

Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus.
Paul J Dunford, Kacy N Williams, Pragnya J Desai, Lars Karlsson, Daniel McQueen, Robin L Thurmond. J Allergy Clin Immunol 2007
214
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.